HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allergic contact dermatitis from the preservative 1,2-benzisothiazolin-3-one (1,2-BIT; Proxel): a case report, its prevalence in those occupationally at risk and in the general dermatological population, and its relationship to allergy to its analogue Kathon CG.

Abstract
Occupational contact allergy to 1,2-benzisothiazolin-3-one (1,2-BIT, Proxel) is analysed. This compound is widely used in industry as a preservative in water-based solutions such as pastes, paints and cutting oils. The optimal concentration for patch testing proved to be 0.4 g/l (0.04%) in water. In 4 out of 17 patients (23%) at occupational risk (painters, paper-hangers), contact allergy to 1,2-BIT was found. Of 556 consecutive dermatological patients without clear occupational risk, 10 (1.8%) showed positive patch tests to 1,2-BIT; in 3 patients 1,2-BIT contact allergy was related to domestic paper-hanging. Although the chemical structure of 1,2-BIT shows some analogy with the preservative Kathon CG, true cross-sensitivity was found to be unlikely.
AuthorsR J Damstra, W A van Vlotten, C J van Ginkel
JournalContact dermatitis (Contact Dermatitis) Vol. 27 Issue 2 Pg. 105-9 (Aug 1992) ISSN: 0105-1873 [Print] England
PMID1395609 (Publication Type: Journal Article)
Chemical References
  • Preservatives, Pharmaceutical
  • Thiazoles
  • Kathon 886
  • 1,2-benzisothiazoline-3-one
Topics
  • Adult
  • Dermatitis, Contact (etiology)
  • Dermatitis, Occupational (etiology)
  • Female
  • Hand Dermatoses (chemically induced)
  • Humans
  • Male
  • Middle Aged
  • Patch Tests
  • Preservatives, Pharmaceutical (adverse effects)
  • Thiazoles (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: